143 related articles for article (PubMed ID: 36181317)
1. American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma.
Schmalbach CE; Ow TJ; Choi KY; O'Leary M; Lin A; Hughley BB; Emerick KS; Moore B; Lee NY; Zandberg DP; Wang SJ
Head Neck; 2023 Jan; 45(1):32-41. PubMed ID: 36181317
[TBL] [Abstract][Full Text] [Related]
2. Management of the parotid for high-risk cutaneous squamous cell carcinoma: A review from the salivary section of the American Head and Neck Society.
Kejner AE; Harris BN; Patel R; McMullen C; Weir J; Dahshan BA; Carroll WR; Gillespie MB
Am J Otolaryngol; 2022; 43(2):103374. PubMed ID: 35158264
[TBL] [Abstract][Full Text] [Related]
3. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
4. PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California.
In GK; Vaidya P; Filkins A; Hermel DJ; King KG; Ragab O; Tseng WW; Swanson M; Kokot N; Lang JE; Menendez L; DeClerck B; Kim G; Hu JC; Terando A; Jadvar H; Ricker C; Miller KA; Peng DH; Wysong A
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1803-1811. PubMed ID: 33210210
[TBL] [Abstract][Full Text] [Related]
5. PD-1 inhibitors for cutaneous squamous cell carcinoma: A meta-analysis.
Aboul-Fettouh N; Chen L; Ma J; Patel J; Silapunt S; Migden M
Australas J Dermatol; 2022 Feb; 63(1):36-42. PubMed ID: 34699068
[TBL] [Abstract][Full Text] [Related]
6. Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement.
Shindo ML; Caruana SM; Kandil E; McCaffrey JC; Orloff LA; Porterfield JR; Shaha A; Shin J; Terris D; Randolph G
Head Neck; 2014 Oct; 36(10):1379-90. PubMed ID: 24470171
[TBL] [Abstract][Full Text] [Related]
7. Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma.
Rabinowits G; Migden MR; Schlesinger TE; Ferris RL; Freeman M; Guild V; Koyfman S; Pavlick AC; Swanson N; Wolf GT; Dinehart SM
JID Innov; 2021 Dec; 1(4):100045. PubMed ID: 34909742
[TBL] [Abstract][Full Text] [Related]
8. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
9. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
11. Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging.
Watts F; Palme CE; Porceddu S; Sundaresan P; Clark JR; Gupta R
Surgery; 2021 Nov; 170(5):1467-1473. PubMed ID: 34130810
[TBL] [Abstract][Full Text] [Related]
12. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
Amit M; Liu C; Netto Gleber FO; Kini S; Tam S; Benov A; Aashiq M; El-Naggar AK; Moreno AC; Rosenthal DI; Glisson BS; Ferrarotto R; Wong MK; Migden MR; Li G; Khanna A; Goepfert RP; Nagarajan P; Weber RS; Myers JN; Gross ND
Eur J Cancer; 2021 Feb; 144():169-177. PubMed ID: 33352413
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression Impact on Head and Neck Cutaneous Squamous Cell Carcinoma: A Systematic Review with Meta-analysis.
Elghouche AN; Pflum ZE; Schmalbach CE
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):439-446. PubMed ID: 30348055
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma.
Giri A; Bauman JR
Expert Rev Anticancer Ther; 2022 Oct; 22(10):1029-1038. PubMed ID: 36106496
[TBL] [Abstract][Full Text] [Related]
15. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of programmed cell death-1 inhibitor therapy for advanced-stage cutaneous squamous cell carcinoma in solid-organ transplant recipients.
Hanania HL; Lewis DJ
J Dermatolog Treat; 2022 Dec; 33(8):3119-3126. PubMed ID: 36018250
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.
Poulose JV; Kainickal CT
World J Clin Oncol; 2022 May; 13(5):388-411. PubMed ID: 35662989
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms.
Nightingale J; Gandhi M; Helena J; Bowman J; McGrath M; Coward J; Porceddu S; Ladwa R; Panizza B
Head Neck; 2022 May; 44(5):1099-1105. PubMed ID: 35156249
[TBL] [Abstract][Full Text] [Related]
19. Clinical Perineural Invasion and Immunotherapy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Wu MP; Reinshagen KL; Cunnane MB; Shalhout SZ; Kaufman HL; Miller D; Emerick KS
Laryngoscope; 2022 Jun; 132(6):1213-1218. PubMed ID: 34797598
[TBL] [Abstract][Full Text] [Related]
20. Treatment approaches in immunosuppressed patients with advanced cutaneous squamous cell carcinoma.
Willenbrink TJ; Jambusaria-Pahlajani A; Arron S; Seckin D; Harwood CA; Proby CM
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():57-60. PubMed ID: 31833603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
